EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 4.9

ph-index = 7

Forward Citations = 324(Granted Patents)

Location History:

West Caldwell, NJ (US) (1999 - 2016)
Monmouth Junction, NJ (US) (2016 - 2017)

Company Filing History:

11 out of 43

Praecis Pharmaceuticals, Inc.

patents

6 out of 6

Provid Pharmaceuticals Inc.

patents

2 out of 1,455

Rutgers, the State University of New Jersey

The United States of America, As Represented by the Secretary, Department of Health and Human Services

University of California

patents

8. 1 out of 14

Cognosci, Incorporated

patents

9. 1 out of 4,945

Hoffmann-la Roche Inc.

patents

where one patent can have more than one assignee

Years Active: 1999-2017

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9592221 - Antibacterial agents: aryl myxopyronin derivatives (2017-03-14),

2. 9315495 - Antibacterial agents: aryl myxopyronin derivatives (2016-04-19),

3. 9278089 - Method of treating HCV infection with a small molecule CHK2 inhibitor (2016-03-08),

4. 8765802 - Kinase inhibitors, compositions thereof, and methods of use therewith (2014-07-01),

5. 8598312 - Inhibitors of antigen presentation by MHC class II molecules (2013-12-03),

6. 8222215 - Methods for the use of inhibitors of antigen presentation by MHC class II molecules (2012-07-17),

7. 7981885 - Compositions for treatment of diseases related to activated lymphocytes (2011-07-19),

8. 7947645 - APO E analogs and methods for their use (2011-05-24),

9. 7923445 - Methods for treatment of diseases related to activated lymphocytes (2011-04-12),

10. 7803774 - Modulators of β-amyloid peptide aggregation (2010-09-28),

11. 7439231 - Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof (2008-10-21),

12. 7432342 - Kinase anchor protein muteins, peptides thereof and related documents (2008-10-07),

13. 7405194 - Therapeutic agents and methods of use thereof for the treatment of melanoma (2008-07-29),

14. 7348307 - Methionine aminopeptidase-2 inhibitors and methods of use thereof (2008-03-25),

15. 7268111 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2007-09-11),

Title: The Innovative Mind of Christopher Self

Introduction: Christopher Self, a talented inventor hailing from West Caldwell, NJ, has made significant contributions to the world of technology and innovation.

Latest Patents: Christopher Self holds several patents in the field of renewable energy technologies, including a groundbreaking solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the industry, Christopher Self has worked for top renewable energy companies, leading research and development teams to create cutting-edge solutions for a sustainable future.

Collaborations: Throughout his career, Christopher Self has collaborated with renowned scientists and engineers from prestigious universities and research institutions, fostering a culture of innovation and excellence in every project.

Conclusion: Christopher Self's passion for innovation and his dedication to creating a greener world through technology make him a true pioneer in the field of renewable energy. His inventive spirit continues to inspire the next generation of inventors and engineers.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com

3 patents pending (EPO):

Please report any incorrect information to support@idiyas.com